AT-406 - Search Results | AbMole BioScience

About 5 results found for searched term "AT-406" (0.127 seconds)

Cat.No.	Name	Target
M2026	AT-406	IAP
	SM-406; Xevinapant; Debio 1143
	Xevinapant (Debio1143,AT-406, SM-406) is a potentially first-in-class, highly potent oral antagonist of inhibitor of apoptosis protein (IAP), which not only promotes cancer cell death by inhibiting IAP, but also It can enhance the anti-tumor immune response by inhibiting IAP.
M13549	Xevinapant hydrochloride	IAP
	AT-406 hydrochloride; Debio 1143 hydrochloride; SM-406 hydrochloride
	Xevinapant (AT-406) hydrochloride is a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs).
M7534	SSR240612	Bradykinin Receptor
	Treatment with the kinin B1 receptor antagonist, SSR240612, provided a protective effect against organ damage by interfering with multiple target functions, including the suppression of B1R-induced inflammation and platelet aggregation.
M14917	Fostamatinib disodium hexahydrate	Syk
	R788 disodium hexahydrate
	Fostamatinib (R788) disodium hexahydrate is the oral prodrug of the active compound R406.
M27952	L-670596	Prostaglandin Receptor
	L-670596 is an orally active and selective thrombsxane A2 receptor/prostaglandin receptor antagonist. L-670596 inhibits arachidonic acid and U-44069 induced bronchoconstriction in the guinea pig. L-670596 also inhibits the aggregation of human platelet rich plasma induced by U-44069.